We are live on ! Find out more
AVDL

Avadel Pharmaceuticals
AVDL

Delisted

AVDL was delisted on the 11th of February, 2026.

Back to rankings

49 hedge funds and large institutions have $28.2M invested in Avadel Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 18 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

3.08% more ownership

Funds ownership: 49.41% → 52.49% (+3.1%)

17% less funds holding

Funds holding: 59 → 49 (-10)

45% less capital invested

Capital invested by funds: $51M → $28.2M (-$22.8M)

56% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 18

83% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 12

Holders
49
Holders Change
-10
Holders Change %
-16.95%
% of All Funds
1.06%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
8
Reduced
18
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Deutsche Bank
Deutsche Bank
Germany
+$1.3M
2
BCM
Brown Capital Management
Maryland
+$688K
3
Renaissance Technologies
Renaissance Technologies
New York
+$83.3K
4
WS
Wedbush Securities
California
+$80.4K
5
Ameriprise
Ameriprise
Minnesota
+$75.2K

Top Sellers

Rank Fund Capital Flow
1
FI
Fosun International
China
-$735K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$536K
3
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
-$366K
4
HCM
Highbridge Capital Management
New York
-$253K
5
Citadel Advisors
Citadel Advisors
Florida
-$250K
Name Holding Trade Value Shares
Change 		Change in
Stake
BIP
1
Brandes Investment Partners
California
$10.2M -$150K -66,334 -0.9%
BC
2
Broadfin Capital
New York
$4.47M – – –
DM
3
Deerfield Management
New York
$3.92M – – –
BCM
4
Brown Capital Management
Maryland
$2.02M +$688K +304,130 +28%
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$1.22M -$536K -236,902 -22%
TCM
6
Tekla Capital Management
Massachusetts
$1.17M – – –
Morgan Stanley
7
Morgan Stanley
New York
$1.03M -$21.2K -9,361 -1%
Renaissance Technologies
8
Renaissance Technologies
New York
$948K +$83.3K +36,836 +6%
Deutsche Bank
9
Deutsche Bank
Germany
$864K +$1.3M +576,795 +2,413%
Ameriprise
10
Ameriprise
Minnesota
$773K +$75.2K +33,231 +7%
JAM
11
JW Asset Management
Florida
$640K – – –
State Street
12
State Street
Massachusetts
$128K – – –
California Public Employees Retirement System
13
California Public Employees Retirement System
California
$122K – – –
COPPSERS
14
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$112K – – –
Millennium Management
15
Millennium Management
New York
$93K -$19K -8,393 -11%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$53K – – –
WS
17
Wedbush Securities
California
$51K +$80.4K +35,535 New
EVM
18
Eaton Vance Management
Massachusetts
$50K – – –
IAMOG
19
Investors Asset Management of Georgia
Georgia
$50K +$1.13K +500 +1%
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$49K -$27K -11,949 -26%
FDCDDQ
21
Federation des caisses Desjardins du Quebec
Quebec, Canada
$41.7K – – –
Susquehanna International Group
22
Susquehanna International Group
Pennsylvania
$39K -$14.3K -6,321 -19%
State of Tennessee, Department of Treasury
23
State of Tennessee, Department of Treasury
Tennessee
$31K -$4.65K -2,055 -9%
CLOS
24
Compagnie Lombard Odier SCmA
Switzerland
$28K – – –
CS
25
Credit Suisse
Switzerland
$27K +$42.1K +18,601 New
1
2 3

AVDL Hedge Fund Activity: Q1 2019 in Review

49 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Avadel Pharmaceuticals (AVDL) for Q1 2019, worth a combined $28.2M — down 45% from $51M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of AVDL and 2 opened new positions — a net loss of 10 holders — while 18 trimmed existing stakes and 8 added.

The largest buyer was Deutsche Bank, adding an estimated $1.3M. The largest seller was Fosun International, cutting an estimated $735K.

  • 49 institutional investors held Avadel Pharmaceuticals (AVDL) as of Q1 2019, down from 59 in Q4 2018.
  • Funds reported $28.2M of Avadel Pharmaceuticals stock for Q1 2019, down 45% quarter-over-quarter.
  • 2 funds opened new Avadel Pharmaceuticals positions in Q1 2019 and 12 closed out, a net change of -10 holders.
  • The largest Avadel Pharmaceuticals buyer in Q1 2019 was Deutsche Bank, an estimated $1.3M added.
  • The largest Avadel Pharmaceuticals seller in Q1 2019 was Fosun International, an estimated $735K sold.

Based on aggregated 13F filings for Q1 2019.